Inventor · disambiguated record
Nianshuang Wang
Also filed as: WANG NIANSHUANG
5 granted patents·10 pending applications·25 citations·filing 2017–2025
72Inventor score
Files withREGENERON PHARMA6UNIV TEXAS5US HEALTH2THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN1UNIV VANDERBILT1
Top patents by PatentIndex Score
15 records- 0193US10960070B2Prefusion coronavirus spike proteins and their useUS HEALTH·Filed 2017·Granted Mar 30, 2021·25 cites·23 claims
- 0285US12304930B2Prefusion-stabilized hMPV F proteinsUNIV TEXAS·Filed 2024·Granted May 20, 2025·0 cites·18 claims
- 0383US12077563B2Prefusion-stabilized hMPV F proteinsUNIV TEXAS·Filed 2024·Granted Sep 3, 2024·0 cites·28 claims
- 0479US11919927B2Prefusion-stabilized hMPV F proteinsUNIV TEXAS·Filed 2023·Granted Mar 5, 2024·0 cites·30 claims
- 0575US2025257102A1Prefusion-stabilized hmpv f proteinsUNIV TEXAS·Filed 2025·Application pending·0 cites
- 0670US2025154487A1Engineered alpha klotho polypeptides and uses thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0768US2024252601A1Ace2 fusion proteins and uses thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0866US11964010B2Prefusion coronavirus spike proteins and their useUS HEALTH·Filed 2021·Granted Apr 23, 2024·0 cites·15 claims
- 0966US2024287162A1Multivalent anti-spike protein binding molecules and uses thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1066US2024309072A1Multivalent anti-spike protein binding molecules and uses thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1166US2024307512A1ACE2-IgM-Fc FUSION PROTEINS AND USES THEREOFREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1255US2025376667A1Engineered alpha klotho polypeptides and uses thereofREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1352US2023242594A1Engineered coronavirus spike (s) protein and methods of use thereofUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1451US2023113170A1Sars-cov-2 vaccineTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN·Filed 2021·Application pending·0 cites
- 1551US2023348571A1Cross-reactive coronavirus antibodies and uses thereofUNIV VANDERBILT·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nianshuang Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →